Long-Term Clinical Benefit and Prolonged Tumor Response Seen With 40.7% Objective Response Rate No New Safety Signals Observed Longest Follow-Up of Patients Treated With a KRASG12C Inhibitor THOUSAND OAKS, CA –– Amgen (NASDAQ:… Read More
Managing Intellectual Property (MIP) has named Gowling WLG the Canadian “Patent Contentious Firm of the Year” at the MIP Americas Awards 2022. Last night, Ottawa partner Christopher Van Barr, who was nominated… Read More
Orally bioavailable ANITAC™ degraders can eliminate full length, mutant and splice variant forms of AR that are expressed in castration-resistant prostate cancer (CRPC) patients ANITAC degraders inhibit AR-dependent transcription and reduce… Read More
VANCOUVER, BC — AbCellera (Nasdaq: ABCL), a technology company focused on next-generation antibody discovery, today announced the release of data on its new T cell engager platform at the American Association… Read More
VANCOUVER, British Columbia – Life Sciences British Columbia (LSBC) is proud to announce the graduating companies from its annual Investor Readiness Program (IRP), which runs from September to March and pairs… Read More
